Lv5
990 积分 2020-10-02 加入
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
2天前
已完结
Disagreements Between FDA and its Oncologic Drugs Advisory Committee (ODAC)
6天前
已完结
CAR T cell immunotherapy for human cancer
1个月前
已完结
Investigational Agents Targeting SGLT1 and SGLT2 in the Treatment of Type 2 Diabetes Mellitus
1个月前
已完结
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
1个月前
已完结
SGLT1 inhibition: Pros and cons
1个月前
已完结
Reflections on Advances in Cancer Research in 2024
3个月前
已完结
Precision Oncology: 2024 in Review
3个月前
已完结
Cancer in 2024
3个月前
已关闭
Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval
5个月前
已完结
皖公网安备34019202002308
